Moderna
MRNA
#1355
Rank
S$17.79 B
Marketcap
$46.24
Share price
0.89%
Change (1 day)
-65.41%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$17.79 Billion

As of January 2025 Moderna has a market cap of S$17.79 Billion. This makes Moderna the world's 1355th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025S$17.79 B-15.22%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Jan 20th, 2025 the market cap of Moderna was reported to be:

S$17.79 Billion
by Yahoo Finance info icon info icon
S$17.79 Billion
by CompaniesMarketCap info icon info icon
S$17.79 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.11 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$336.31 B 1,789.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.13 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.12 B 142.35%๐Ÿ‡บ๐Ÿ‡ธ USA
S$264.78 B 1,387.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$3.30 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$480.62 B 2,600.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.04 B-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA